Q: With apologies to the members who do not appreciate US content, I am hopeful to get your thoughts on Quidel. How would you assess its potential for capital appreciation in the next year or two? There is a Covid angle which is almost a reason not to buy in my opinion (it has to end right?) but other business opportunities as well. Thoughts on whether to buy, sell or hold and why if you can please.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: would it be to late to purchase Abbvie after this big run in price.
Q: There has been quite a fall in ATE's share price in the last week. Do you have any information on this? Do you see any upside, or is it time to let it go?
Q: With Endo's latest issues and a multi year low for their stock price, is it time to act for Mr Goodman? It would be great for GUD to go after the Paladin business. Endo needs the cash.
Can they do it? Should they?
Can they do it? Should they?
Q: Sorrento Therapeutics Inc. is hot on the Vaccine trail. along with MRNA & NVAX. Would you have an opinion on it?
Thanks! Austin
Thanks! Austin
Q: I am interested in WELL and have been watching it for some time, but I have one nagging question I wanted to ask. I was part of the PHM hype a few years ago and was flying high (like everyone) until it came crashing down. The hype around WELL as well as being in the healthcare space reminds me a lot of PHM. But is that where the similarities end? Do you like it at today's levels? Thanks.
Q: what is going on with this stock
Q: What is your outlook for prn ?
Q: Would you give me your opinion on Titan Medical for a longer tern buy? Thank you. cheers
Q: Can you give me your opinion on CloudMD?
Q: Any reason not to sell xhc and buy life. I want stability but income is very important. Thanks, J
Q: Hi 5i,
I have held GILD for a number of years, and now that a merger is announced would it be a buy, sell or hold. Do mergers of equal typically result in higher stock purchase prices?
I have held GILD for a number of years, and now that a merger is announced would it be a buy, sell or hold. Do mergers of equal typically result in higher stock purchase prices?
Q: Down 14% premarket, Any reason for this?
Q: Really perturb with the performance,or should I said non-performance,of GUD especially with the recent downturn when the N.A. markets had rallied so much from the March lows.It delayed report of Q till June 26.Please comment & maybe have to wait till 6/26 when its results will include its big acquisition.Txs for u usual great advices & services
-
iShares Global Healthcare Index ETF (CAD-Hedged) (XHC $61.60)
-
Evolve Global Healthcare Enhanced Yield Fund (LIFE $18.21)
Q: Hi 5iTeam,
Both of the above 2 ETFs are pretty well100% focused on health care with very similar make up (65% US, 35% non-US), why then there is such a big difference in dividend yield, Life pays 7.1% while XHC pays 1.05% in dividend.
Cheers,
Both of the above 2 ETFs are pretty well100% focused on health care with very similar make up (65% US, 35% non-US), why then there is such a big difference in dividend yield, Life pays 7.1% while XHC pays 1.05% in dividend.
Cheers,
Q: Van Eck Vectors Biotech E.T.F. BBH (Nasdaq)
1. I rarely buy ETFs. When I do, I favor ones with less than 50 holdings. I am under the impression that an ETF with a large number of holdings is so diluted that you tend not to get as much upside/downside. Is this this approach favoring higher beta better or worse than one that ignores the number of holdings?
2. BBH has a relatively concentrated portfolio of 26 biotech businesses.
3. Your insight into BBH please? Substance only please; have already reviewed material including ETF.com, ETF Channel.
4. If you think others are better , please do suggest names. I have not researched IBB or XBB.
1. I rarely buy ETFs. When I do, I favor ones with less than 50 holdings. I am under the impression that an ETF with a large number of holdings is so diluted that you tend not to get as much upside/downside. Is this this approach favoring higher beta better or worse than one that ignores the number of holdings?
2. BBH has a relatively concentrated portfolio of 26 biotech businesses.
3. Your insight into BBH please? Substance only please; have already reviewed material including ETF.com, ETF Channel.
4. If you think others are better , please do suggest names. I have not researched IBB or XBB.
Q: Do you have any information as to why the stock popped today? No news that I can find. Thank you.
Q: I’ve patiently held GUD for 4 years now without it doing much. Could you recommend 1 or 2 replacements from the Healthcare sector in the U.S. ?
I don’t understand the healthcare business myself, so I’m looking for a company with solid management that I can invest in, and then just forget about it for years to come.
I don’t understand the healthcare business myself, so I’m looking for a company with solid management that I can invest in, and then just forget about it for years to come.
Q: Hi,
Does this a company have good growth potential and is it financially sound?
Thank you
Does this a company have good growth potential and is it financially sound?
Thank you
Q: you indicate that you think management has performed well yet the performance of management is on the minus side for all three criteria on management performance Why the difference or is there underlying conditions that are not obvious to us that rely on information from your sources